318 related articles for article (PubMed ID: 31635968)
1. Infection in cirrhosis: A prospective study.
Bhattacharya C; Das-Mondal M; Gupta D; Sarkar AK; Kar-Purkayastha S; Konar A
Ann Hepatol; 2019; 18(6):862-868. PubMed ID: 31635968
[TBL] [Abstract][Full Text] [Related]
2. A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
Vasudevan A; Mukhopadhyay A; Li J; Yuen EG; Tambyah PA
BMC Infect Dis; 2014 Nov; 14():615. PubMed ID: 25420613
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis.
Cheong HS; Kang CI; Lee JA; Moon SY; Joung MK; Chung DR; Koh KC; Lee NY; Song JH; Peck KR
Clin Infect Dis; 2009 May; 48(9):1230-6. PubMed ID: 19302016
[TBL] [Abstract][Full Text] [Related]
4. Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009.
Zilberberg MD; Shorr AF
Infect Control Hosp Epidemiol; 2013 Sep; 34(9):940-6. PubMed ID: 23917908
[TBL] [Abstract][Full Text] [Related]
5. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
Pang F; Jia XQ; Zhao QG; Zhang Y
Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
[TBL] [Abstract][Full Text] [Related]
6. Patients with cirrhosis and SBP: Increase in multidrug-resistant organisms and complications.
Li H; Wieser A; Zhang J; Liss I; Markwardt D; Hornung R; Neumann-Cip AC; Mayerle J; Gerbes A; Steib CJ
Eur J Clin Invest; 2020 Feb; 50(2):e13198. PubMed ID: 31886517
[TBL] [Abstract][Full Text] [Related]
7. Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients.
Li YT; Yu CB; Huang JR; Qin ZJ; Li LJ
World J Gastroenterol; 2015 Sep; 21(36):10409-17. PubMed ID: 26420967
[TBL] [Abstract][Full Text] [Related]
8. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections.
Lodise TP; Bonine NG; Ye JM; Folse HJ; Gillard P
BMC Infect Dis; 2019 Aug; 19(1):718. PubMed ID: 31412809
[TBL] [Abstract][Full Text] [Related]
9. [Mortality risk factors for bloodstream infections caused by extended-spectrum beta-lactamase-producing microorganisms].
Ferrández O; Grau S; Saballs P; Luque S; Terradas R; Salas E
Rev Clin Esp; 2011 Mar; 211(3):119-26. PubMed ID: 21371702
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance in community-acquired urinary tract infections in Paris in 2015.
Chervet D; Lortholary O; Zahar JR; Dufougeray A; Pilmis B; Partouche H
Med Mal Infect; 2018 May; 48(3):188-192. PubMed ID: 29054298
[TBL] [Abstract][Full Text] [Related]
11. [Microbiological profile of infections in the Intensive Care Units of Colombia (EPISEPSIS Colombia].
Molina FJ; Díaz CA; Barrera L; De La Rosa G; Dennis R; Dueñas C; Granados M; Londoño D; Ortiz G; Rodríguez F; Jaimes F
Med Intensiva; 2011 Mar; 35(2):75-83. PubMed ID: 21334104
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.
Fernández J; Acevedo J; Castro M; Garcia O; de Lope CR; Roca D; Pavesi M; Sola E; Moreira L; Silva A; Seva-Pereira T; Corradi F; Mensa J; Ginès P; Arroyo V
Hepatology; 2012 May; 55(5):1551-61. PubMed ID: 22183941
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for acquiring potentially drug-resistant pathogens in immunocompetent patients with pneumonia developed out of hospital.
Jeong BH; Koh WJ; Yoo H; Park HY; Suh GY; Chung MP; Kwon OJ; Jeon K
Respiration; 2014; 88(3):190-8. PubMed ID: 24994099
[TBL] [Abstract][Full Text] [Related]
14. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.
Alexopoulou A; Vasilieva L; Agiasotelli D; Siranidi K; Pouriki S; Tsiriga A; Toutouza M; Dourakis SP
World J Gastroenterol; 2016 Apr; 22(15):4049-56. PubMed ID: 27099449
[TBL] [Abstract][Full Text] [Related]
15. Changes in the incidence and antimicrobial susceptibility of healthcare-associated infections in a New York hospital system, 2006-2012.
Cohen B; Liu J; Larson E
J Prev Med Hyg; 2017 Dec; 58(4):E294-E301. PubMed ID: 29707660
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis.
Lutz P; Nischalke HD; Krämer B; Goeser F; Kaczmarek DJ; Schlabe S; Parcina M; Nattermann J; Hoerauf A; Strassburg CP; Spengler U
Eur J Clin Invest; 2017 Jan; 47(1):44-52. PubMed ID: 27861767
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and outcome of bacteremia caused by extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in a tertiary care teaching hospital in south India.
Abhilash KP; Veeraraghavan B; Abraham OC
J Assoc Physicians India; 2010 Dec; 58 Suppl():13-7. PubMed ID: 21563608
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience.
Veeraraghavan B; Shankar C; Karunasree S; Kumari S; Ravi R; Ralph R
Pathog Glob Health; 2017 Jul; 111(5):240-246. PubMed ID: 28670975
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia.
Seo H; Lee SC; Chung H; Ra SH; Sung H; Kim MN; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Woo JH; Chong YP
Int J Antimicrob Agents; 2020 Oct; 56(4):106126. PubMed ID: 32755654
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of risk factors for colistin resistance among uropathogenic isolates of Escherichia coli and Klebsiella pneumoniae: a case-control study.
Kaza P; Mahindroo J; Veeraraghavan B; Mavuduru RS; Mohan B; Taneja N
J Med Microbiol; 2019 Jun; 68(6):837-847. PubMed ID: 31084700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
